Cargando…

PMON102 Utility of the Desmopressin Stimulation Test to Detect Cyclic Cushing's Disease

BACKGROUND: Arginine-vasopressin stimulates pituitary ACTH secretion after binding to arginine-vasopressin receptor 1B on corticotropes. Desmopressin (DDAVP), which preferentially binds to arginine-vasopressin receptor 2, stimulates the release of ACTH in most patients with pituitary corticotrope ad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elenius, Henrik, McGlotten, Raven, Chitticoina, Prashant, Drake, William, Nieman, Lynnette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Neuroendocrinology and Pituitary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625414/ http://dx.doi.org/10.1210/jendso/bvac150.1100

Ejemplares similares

THU039 Use Of Desmopressin In The Differential Diagnosis Of Cushing’s Syndrome: Recent Experience At The NIH
por: McGlotten, Raven, et al.
Publicado: (2023)

PMON73 Lipid profile in patients with Cushing's syndrome and the impact of surgical treatment
por: Varghese, Ron, et al.
Publicado: (2022)

THU030 Evaluation Of Combined CRH And HDDST Test Performance
por: Elenius, Henrik, et al.
Publicado: (2023)

MON-444 Defining Remission In Cushing Syndrome After Tumor Resection In Cases Of Non-suppressed Postoperative Serum Cortisol Levels
por: McGlotten, Raven, et al.
Publicado: (2019)

SAT-459 Hypothalamic-Pituitary-Gonadal (HPG) and Hypothalamic-Pituitary-Thyroid (HPT) Axes in Cushing Syndrome (CS): A Retrospective Cohort Study
por: Shekhar, Skand, et al.
Publicado: (2019)

SAT-254 Desmopressin Stimulation Test in a Pregnant Patient with Cushing’s Syndrome
por: Warachit, Wasita, et al.
Publicado: (2020)

MON-LB078 Desmopressin Stimulated Salivary Cortisol as a Suplementary Tool in the Diagnosis of Cushing's Syndrome
por: Firme, Ricardo
Publicado: (2019)

PMON149 Identification of TR4 Modulators for Treatment of Cushing Disease.
por: Zhang, Dongyun, et al.
Publicado: (2022)

RF01 | PMON167 Isolated Cushing's Disease Associated With Rare Germline SDHx Variants
por: Chittiboina, Prashant, et al.
Publicado: (2022)

OR23-01 Intrapatient ACTH Variability in Cushing’s Disease: Prognostic Significance
por: Alvarez, Reinier, et al.
Publicado: (2020)

MON-178 Cyclical Cushing’s Syndrome in 12 Patients with Ectopic ACTH Secretion
por: Zenno, Anna, et al.
Publicado: (2020)

PMON87 A Case of Mineralocorticoid Induced Hypertension Secondary to Cushing's Syndrome
por: Abideen, Zain U, et al.
Publicado: (2022)

SAT-304 Pituitary Stem Cells May Drive Adenomas Causing Cushing’s Disease
por: Asuzu, David, et al.
Publicado: (2020)

PMON94 Collision tumor with Rathke cleft cyst and co existing Cushing's disease
por: Mittal, Ashima, et al.
Publicado: (2022)

Desmopressin Test in Silent Corticothoph Pituitary Adenomas, a Preliminary Study - a Comparison With Cushing Disease
por: Huayllas, Martha Katherine, et al.
Publicado: (2021)

FRI355 Hypokalemia-induced Nephrogenic Diabetes Insipidus In A Patient With Medullary Thyroid Carcinoma And Paraneoplastic Cushing’s Syndrome
por: Jhawar, Sakshi, et al.
Publicado: (2023)

SAT-300 Evading Death: Noxa in Cushing’s Disease Pituitary Adenomas
por: Alvarez, Reinier, et al.
Publicado: (2020)

PMON93 Adenoma Size & Inferior Petrosal Sinus Sampling in Cushing's Disease Diagnosis - Smoke & Mirrors?
por: Hashmi, Hiba, et al.
Publicado: (2022)

MON-295 Desmopressin Test in Silent Corticothoph Pituitary Adenomas, a Preliminary Study - a Comparison with Cushing Disease
por: Huayllas, Martha Katherine, et al.
Publicado: (2020)

SUN-462 Petrous Sinus Catheterization, Baseline and after Stimulation with Desmopressin, for the Diagnosis of Cushing's Disease, Experience of a National Health Institute in Mexico
por: León-Suárez, Andrés, et al.
Publicado: (2019)

MON-162 Utility of 24-Hour Urine Cortisone for the Diagnosis of Cushing’s Syndrome
por: McGlotten, Raven, et al.
Publicado: (2020)

OR01-02 Epigenomic Dysregulation Of PPP1R17 Drives The Cell Cycle In Adenomas Causing Cushing’s Disease
por: Asuzu, David, et al.
Publicado: (2023)

Resolution of Abnormal Gonadotropin Secretion After Surgical Cure in Men With ACTH-Dependent Cushing Syndrome
por: Shekhar, Skand, et al.
Publicado: (2021)

PMON123 Diagnostically Challenging Case of Cushing's Syndrome from a Pancreatic Neuroendocrine Tumor Treated with Radiofrequency Ablation
por: Gugger, Aristea Sideri, et al.
Publicado: (2022)

SUN-368 Fatty Hypertrophy of the Hip as a Clinical Manifestation of Cushing Syndrome
por: McGlotten, Raven, et al.
Publicado: (2019)

PMON98 High-dose dexamethasone suppression test in ACTH-dependent Cushing's syndrome: Lessons learned on the lack of cortisol suppression
por: Ali, Roshaneh, et al.
Publicado: (2022)

PMON152 In Patients with Cushing's Disease and a Visible Tumor on MRI, IPSS does not Add to the Accuracy of Predicting Tumor Lateralization
por: Lundholm, Michelle D, et al.
Publicado: (2022)

PMON80 Case of Cushing's Disease That Presented as Diabetic Ketoacidosis and Successfully Treated With Stereotactic Radiosurgery During the COVID-19 Pandemic
por: Cadeliña, Jekrylei, et al.
Publicado: (2022)

SAT320 Cyclic Cushing Syndrome Caused By An ACTH-Producing Pheochromocytoma
por: Omotosho, Yetunde Bernice, et al.
Publicado: (2023)

ODP304 Cyclic Cushing Disease: A Diagnostic Challenge
por: Zubiran, Rafael, et al.
Publicado: (2022)

PMON165 Favorable Liver Safety Profile of the Selective Glucocorticoid Receptor Modulator Relacorilant in Healthy and Hepatically Impaired Adults and in Patients with Cushing Syndrome
por: Moraitis, Andreas, et al.
Publicado: (2022)

MON-167 Use of a Morning Cortisol Level to Predict Recovery of the Hypothalamic-Pituitary-Adrenal (HPA) Axis in Secondary Adrenal Insufficiency Following Remission of Cushing’s Syndrome
por: McGlotten, Raven, et al.
Publicado: (2020)

SAT-263 A Vicious Cycle of Hypercortisolism - Cyclical Cushing’s Syndrome
por: Force, Bahar Kapoor, et al.
Publicado: (2020)

SAT-449 Factors Associated with Reduced Thyroid Hormones in Cushing Syndrome Patients Before and After Surgical Cure
por: Shekhar, Skand, et al.
Publicado: (2020)

PMON163 Effect of Osilodrostat on Androgens and Adrenal Hormones in Patients With Cushing's Disease: Long-Term Findings From the Phase III, Prospective LINC 3 Study
por: Fleseriu, Maria, et al.
Publicado: (2022)

PMON160 Improvements in Clinical Signs of Hypercortisolism and Quality of Life According to Urinary and Late-Night Salivary Cortisol Levels in Patients with Cushing's Disease Treated with Osilodrostat
por: Biller, Beverly M K, et al.
Publicado: (2022)

THU538 Use Of Multiple Functional And Structural Imaging Modalities Improves Detection Of Ectopic ACTH Tumors
por: Elenius, Henrik, et al.
Publicado: (2023)

SUN-355 Computed Tomography Appearance of Adrenal Glands in Non-Adrenal Causes of Cushing's Syndrome
por: Bansal, Rashika, et al.
Publicado: (2019)

PMON75 Unilateral Galactorrhea in an Elderly Male
por: Monsour, Elio, et al.
Publicado: (2022)

PMON162 Osilodrostat Provides Sustained Clinical Benefits and Improves Health-Related Quality of Life in Patients with Cushing's Disease: Results from the Phase III LINC 4 Study
por: Feelders, Richard, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0cgh31tnt9pjgguqh0l7pn13ss